Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of the coadministration of valsartan
(Diovan®) 160mg and rosuvastatin (Crestor®) 20mg in comparison to each component administered
alone in patients with hypertension and hyperlipidemia.